2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
申请人:——
公开号:US20030078260A1
公开(公告)日:2003-04-24
This invention relates to novel 2,6-substituted chroman derivatives which are useful in the treatment of beta-3 adrenoreceptor-mediated conditions.
这项发明涉及新颖的2,6-取代的色苷衍生物,可用于治疗β-3肾上腺素受体介导的疾病。
2,6-SUBSTITUTED CHROMAN DERIVATIVES USEFUL AS BETA-3 ADRENORECEPTOR AGONISTS
申请人:Bayer Pharmaceuticals Corporation
公开号:EP1389202A1
公开(公告)日:2004-02-18
US6660752B2
申请人:——
公开号:US6660752B2
公开(公告)日:2003-12-09
US6919371B2
申请人:——
公开号:US6919371B2
公开(公告)日:2005-07-19
[EN] 2,6-SUBSTITUTED CHROMAN DERIVATIVES USEFUL AS BETA-3 ADRENORECEPTOR AGONISTS<br/>[FR] DERIVES DE CHROMANE SUBSTITUES EN 2,6 UTILES COMME AGONISTES DU RECEPTEUR BETA3-ADRENERGIQUE
申请人:BAYER AG
公开号:WO2002085891A1
公开(公告)日:2002-10-31
This invention relates to novel 2,6-substituted chroman derivatives which are useful in the treatment of beta-3 adrenoreceptor-mediated conditions.